Literature DB >> 29775498

The Jarisch-Herxheimer reaction in syphilis: could molecular typing help to understand it better?

M Arando1,2, C Fernandez-Naval3,4, M Mota-Foix5, A Alvarez1, P Armegol1, M J Barberá1, J Esperalba6, M Vall-Mayans1.   

Abstract

OBJECTIVES: The Jarisch-Herxheimer reaction (JHR) is a febrile inflammatory reaction that may occur in patients after treatment of syphilis. The overall rate is estimated to be 10-25% with broad variations over time. It appears to be related to factors like stage of the disease or reagin titres. In this study, we aimed to describe the incidence of and risk factors including strain typing for JHR among patients with syphilis.
METHODS: From January through October 2015, 224 consecutive patients (82 of them with HIV) who were diagnosed with early syphilis were enrolled in this prospective observational study in a referral STI clinic in Barcelona. An appointment was offered to them after 10-14 days of treatment to inquire about the reaction with the use of a standardized form. Treponema pallidum molecular typing was made to detect a possible strain related to reaction.
RESULTS: Overall, 28% of patients developed JHR. This varied from 56% in secondary, 37% in primary to 7% in early latent syphilis. The most frequent types of reaction were fever (57.5%) and worsening of the lesions (31%). The median time to development of JHR was 6 h [IQR 4-10 h] and lasted a median of 9 h [IQR 4-24 h]. The JHR was less probable in early latent compared to primary/secondary syphilis (P = 0.04) and in patients treated with doxycycline compared to those treated with penicillin (P = 0.01). No differences were seen regarding reagin titres or HIV status, and no association with a specific strain was found.
CONCLUSIONS: In this study, JHR occurred in a similar frequency as in other contemporary studies. Symptomatic syphilis and treatment with penicillin were associated with an increased risk of JHR, whereas the previous episode of syphilis was associated with a low risk of it. We could not find associations with specific strains of T. pallidum.
© 2018 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29775498     DOI: 10.1111/jdv.15078

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  Previous Syphilis Alters the Course of Subsequent Episodes of Syphilis.

Authors:  Christina M Marra; Clare L Maxwell; Sharon K Sahi; Lauren C Tantalo; Shelia B Dunaway; Sheila A Lukehart
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

2.  Previous Syphilis Alters the Course of Subsequent Episodes of Syphilis.

Authors:  Christina M Marra; Clare L Maxwell; Sharon K Sahi; Lauren C Tantalo; Shelia B Dunaway; Sheila A Lukehart
Journal:  Clin Infect Dis       Date:  2022-03-01       Impact factor: 9.079

3.  Brazilian Protocol for Sexually Transmitted Infections 2020: acquired syphilis.

Authors:  Francisca Lidiane Sampaio Freitas; Adele Schwartz Benzaken; Mauro Romero Leal de Passos; Ivo Castelo Branco Coelho; Angélica Espinosa Miranda
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

Review 4.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity.

Authors:  Amy Proal; Trevor Marshall
Journal:  Front Pediatr       Date:  2018-12-04       Impact factor: 3.418

5.  High Baseline C-Reactive Protein Level Can Predict the Occurrence of the Jarisch-Herxheimer Reaction in Patients with Active Syphilis.

Authors:  Hung-Chin Tsai; Yen-Hsu Chen; Yu-Ting Tseng; Pei-Yun Chou; Ming-Hong Tai; Chia-Yen Dai; Susan Shin-Jung Lee; Yao-Shen Chen
Journal:  Infect Drug Resist       Date:  2021-12-02       Impact factor: 4.003

6.  Epilepsy and syphilis: A systematic review and meta-analysis.

Authors:  Chao Zhang; Wei Yue; Shuping Hou; Wanzhen Cui; Lei Xiang
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.